[Treatment of sepsis by extracorporeal elimination of endotoxin using fiber-immobilized polymyxin B]. 1993

H Aoki, and T Tani, and K Hanasawa, and H Shoji, and M Kodama
First Department of Surgery, Shiga University of Medical Science, Otsu, Japan.

To remove endotoxin directly from the blood, an affinity adsorbent (PMX) has been developed. PMX is composed of a ligand of polymyxin B and a carrier of polystyrene fibers. We treated 16 patients, suffering from septic shock or multiple organ failure by PMX-F hemoperfusion. The pretreatment level of endotoxin decreased significantly from 80pg/ml to 21pg/ml on average 2 hours after the hemoperfusion. The hyperdynamic status in the cardiac index and the decreased systemic vascular resistance, which are characteristic to endotoxin shock, were normalized after the treatment. In septic shock patients with systolic pressure under 10mmHg, the systolic pressure increased significantly from pretreatment level. Nine of the sixteen patients remained alive for two weeks after the therapy, and seven out of the nine patients discharged alive. Hemoperfusion with PMX is likely to become an effective treatment for sepsis and septic shock.

UI MeSH Term Description Entries
D011112 Polymyxin B A mixture of polymyxins B1 and B2, obtained from BACILLUS POLYMYXA strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for treatment of infections with gram-negative bacteria, but may be neurotoxic and nephrotoxic. Aerosporin,Polymyxin B Sulfate
D011137 Polystyrenes Polymerized forms of styrene used as a biocompatible material, especially in dentistry. They are thermoplastic and are used as insulators, for injection molding and casting, as sheets, plates, rods, rigid forms and beads. Polystyrol,Polystyrene,Polystyrols
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes
D018805 Sepsis Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. Bloodstream Infection,Pyaemia,Pyemia,Pyohemia,Blood Poisoning,Poisoning, Blood,Septicemia,Severe Sepsis,Blood Poisonings,Bloodstream Infections,Infection, Bloodstream,Poisonings, Blood,Pyaemias,Pyemias,Pyohemias,Sepsis, Severe,Septicemias

Related Publications

H Aoki, and T Tani, and K Hanasawa, and H Shoji, and M Kodama
January 2010, Contributions to nephrology,
H Aoki, and T Tani, and K Hanasawa, and H Shoji, and M Kodama
April 2014, The International journal of artificial organs,
H Aoki, and T Tani, and K Hanasawa, and H Shoji, and M Kodama
May 1995, Nihon Geka Gakkai zasshi,
H Aoki, and T Tani, and K Hanasawa, and H Shoji, and M Kodama
February 1998, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis,
H Aoki, and T Tani, and K Hanasawa, and H Shoji, and M Kodama
April 2002, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis,
H Aoki, and T Tani, and K Hanasawa, and H Shoji, and M Kodama
January 2013, Mediators of inflammation,
H Aoki, and T Tani, and K Hanasawa, and H Shoji, and M Kodama
January 2018, Blood purification,
H Aoki, and T Tani, and K Hanasawa, and H Shoji, and M Kodama
October 2014, Journal of critical care,
H Aoki, and T Tani, and K Hanasawa, and H Shoji, and M Kodama
October 2017, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
H Aoki, and T Tani, and K Hanasawa, and H Shoji, and M Kodama
October 2013, Clinical journal of gastroenterology,
Copied contents to your clipboard!